Opinion: Obesity drugs don’t just offer weight loss. They give patients agency
Powerful new obesity drugs like Wegovy and Zepbound have changed how we treat weight and chronic disease. Yet their real promise may lie in the restored belief that we can meaningfully improve our health. As David Kessler, former commissioner of the Food and Drug Administration, has poignantly described, the struggle to lose weight can feel like […]
STAT+: China, where obesity levels are low, becomes hotbed for weight loss drug trials
China has one of the lowest rates of obesity in the developed world. So why has it emerged as one of the top locations for testing the scores of new weight loss drugs cropping up every month? According to a report from clinical research organization Novotech, China is the second-most-popular country for obesity trials in […]
Research reveals how brands can innovate for the growing GLP-1 market
Given the increasing use of GLP-1s, IFF recently released a report highlighting how the rapidly growing GLP-1 consumer market is reshaping the sensory experience and nutritional needs associated with food and drink.
Men Are Claiming Ozempic, GLP-1 Meds Are Making Their Genitals Bigger
Some men have been claiming on social media that their penises have grown larger since they started taking GLP-1 agonist medications like Ozempic.
Advice for trying GLP-1 drugs for weight loss from a doctor who’s been there – NPR
Advice for trying GLP-1 drugs for weight loss from a doctor who’s been there NPRView Full Coverage on Google News
More research links GLP-1 drugs to potentially blinding eye diseases
submitted by /u/TechExpert11 [link] [comments]
Eli Lilly makes all Zepbound doses available in single-dose vials
Eli Lilly said it will make the two highest doses of its popular obesity drug Zepbound available to certain patients in cheaper, single-dose vials. The company first launched single-dose vial formulations for the two lowest …
GLP-1 Drugs May Help in Fibromyalgia, Large Records Study Suggests
(MedPage Today) — BARCELONA — A rheumatology trainee who went on TikTok to find information on her own condition may have uncovered a novel and possibly tectonic approach to treating fibromyalgia, her presentation here suggested. That experience…
Should GLP-1 receptor agonist therapy be used to treat obesity in Bardet-Biedl syndrome?
Bardet-Biedl syndrome (BBS) is a complex genetic condition that can affect multiple organ systems, frequently causing pigmentary retinopathy, renal abnormalities, polydactyly, and obesity. Metabolic disturbances including obesity, unsuppressed appetite, and an increased risk of type 2 diabetes (T2D) present clinical management challenges. In this issue of the JCI, Singh et al. present a mouse model […]
V-type starch-galloyl-based polyphenol complex stimulates GLP-1 and PYY secretion and improves satiety in mice
Publication date: Available online 15 June 2025 Source: Carbohydrate Polymers Author(s): Yimei Zheng, Tonglin Chen, Ke Li, Liang Wang, Xuwei Liu, Lei Zhao, Zhuoyan Hu, Kai Wang